Although MT-II has only been studied clinically for its libido-boosting effects in males, an MT-II analog called PT-141 has been researched extensively in women, and it is already approved for therapy in premenopausal women with hypoactive sexual desire disorder (HSDD)
However, oral weight-loss medications do exist: oral Wegovy (semaglutide) was approved in late 2025, and Foundayo (orforglipron), an oral GLP-1 pill from Eli Lilly, was FDA-approved in April 2026
For example, there have been concerns, such as: Thyroid cancer risk, especially with GLP-1 medications like Ozempic Increased chance of heart attacks or blood clots in certain individuals Worsening high blood pressure, especially when paired with other medications Hormonal shifts that could affect mood, sleep, and erectile dysfunction Anyone considering testosterone replacement therapy TRT should share their full medical history with their doctor
Every peptide we use, including BPC-157, is sourced exclusively from licensed compounding pharmacies that produce human-grade medications
u tin, mi loi thuc c liu lng khc nhau, iu ny c ngha l chng khng th thay th cho nhau m khng cn t vn ca bc s trc